Evidence map›Paper›PMID 33993411›Full record

ArticleThe protein journal2021

Synthesis and Characterization of Novel Chickpea Protein Hydrolysate-Vanadium Complexes Having Cell Inhibitory Effects on Lung Cancer A549 Cells Lines.

Nurkhodja Mukhamedov, Atikan Wubulikasimu, Nigora Rustamova, Rehebati Nuerxiati, Sharafitdin Mirzaakhmedov, Uchqun Ishimov, Jamolitdin Ziyavitdinov, Abulimiti Yili, Haji Akber Aisa

Abstract read
PubMed Publisher
In one paragraph

Article in The protein journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Nurkhodja MukhamedovKey Laboratory of Plants Resources and Chemistry of Arid Zone, Xinjiang Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Urumqi, 830011, People's Republic of China.
Atikan WubulikasimuKey Laboratory of Plants Resources and Chemistry of Arid Zone, Xinjiang Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Urumqi, 830011, People's Republic of China.
Nigora RustamovaKey Laboratory of Plants Resources and Chemistry of Arid Zone, Xinjiang Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Urumqi, 830011, People's Republic of China.
Rehebati NuerxiatiKey Laboratory of Plants Resources and Chemistry of Arid Zone, Xinjiang Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Urumqi, 830011, People's Republic of China.
Sharafitdin MirzaakhmedovInstitute of Bioorganic Chemistry, Tashkent Uzbek Academy of Sciences, Tashkent, Uzbekistan.
Uchqun IshimovInstitute of Bioorganic Chemistry, Tashkent Uzbek Academy of Sciences, Tashkent, Uzbekistan.
Jamolitdin ZiyavitdinovInstitute of Bioorganic Chemistry, Tashkent Uzbek Academy of Sciences, Tashkent, Uzbekistan.
Abulimiti YiliKey Laboratory of Plants Resources and Chemistry of Arid Zone, Xinjiang Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Urumqi, 830011, People's Republic of China. abu@ms.xjb.ac.cn.ORCID 0000-0002-0152-6632
Haji Akber AisaKey Laboratory of Plants Resources and Chemistry of Arid Zone, Xinjiang Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Urumqi, 830011, People's Republic of China.
Chinese Academy of Sciences · CNAcademy of Sciences Republic of Uzbekistan · UZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Designing new types of drugs with preferred properties against cancer is a great issue for scientists dealing with synthesis and study of biological activity. Several organometallic compounds used in chemotherapy reveal side effects. Peptides from edible sources having no side effects may play a transport role in the delivery of anticancer metal ions into targeted tumor cells. For the last two decades, peptide-metal complexes have been considered as potential anticancer agents. In this work, oxovanadium complexes of peptides from Chickpea (Cicer arietinum L.) seeds' protein hydrolysate were investigated. The albumin fraction of Chickpea seeds protein was hydrolyzed with a combination of enzymes papain, trypsin, and alcalase. The hydrolysate was combined with vanadyl ions and obtained oxovanadium complexes were studied by FTIR, SEM-EDX, and TG-DSC analyses, and cell inhibition activity against A549 cells was detected by MTT Assay. In a result, activity of the complexes (IC

Indexed as

Antineoplastic Agents, PhytogenicCoordination ComplexesPlant ProteinsProtein HydrolysatesVanadiumA549 CellsCicerHumansAntineoplastic Agents, PhytogenicCoordination ComplexesPlant ProteinsProtein HydrolysatesVanadiumChickpeaComplexHydrolysisLung cancerMetal binding peptidesVanadium

Identifiers

PMID33993411
OpenAlexW3161780139

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.